Tesamorelin
Tesamorelin is a growth-hormone-releasing hormone (GHRH) analogue studied for the treatment of HIV-associated lipodystrophy, a condition involving abnormal fat deposition. Research also explores its potential to enhance peripheral nerve health, slow the progression of mild cognitive impairment, and reduce fat mass.
Tesamorelin is a growth-hormone-releasing hormone (GHRH) analogue studied for the treatment of HIV-associated lipodystrophy, a condition involving abnormal fat deposition. Research also explores its potential to enhance peripheral nerve health, slow the progression of mild cognitive impairment, and reduce fat mass.
Tesamorelin is a growth-hormone-releasing hormone (GHRH) analogue studied for the treatment of HIV-associated lipodystrophy, a condition involving abnormal fat deposition. Research also explores its potential to enhance peripheral nerve health, slow the progression of mild cognitive impairment, and reduce fat mass.
Storage: Keep refrigerated. Do not freeze. Once opened, the vial can be stored at room temperature for up to 4 weeks.
